Bell JI - Search Results

1

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.

Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, Jensen LT, Huygelen V, Jones EY, Bell JI, Fugger L. Friese MA, et al. Among authors: bell ji. Nat Med. 2008 Nov;14(11):1227-35. doi: 10.1038/nm.1881. Epub 2008 Oct 26. Nat Med. 2008. PMID: 18953350

2

From genes to function: the next challenge to understanding multiple sclerosis.

Fugger L, Friese MA, Bell JI. Fugger L, et al. Among authors: bell ji. Nat Rev Immunol. 2009 Jun;9(6):408-17. doi: 10.1038/nri2554. Nat Rev Immunol. 2009. PMID: 19444306 Review.

3

A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. Lang HL, et al. Among authors: bell ji. Nat Immunol. 2002 Oct;3(10):940-3. doi: 10.1038/ni835. Epub 2002 Sep 3. Nat Immunol. 2002. PMID: 12244309

4

The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.

Hourigan CS, Harkiolaki M, Peterson NA, Bell JI, Jones EY, O'Callaghan CA. Hourigan CS, et al. Among authors: bell ji. Eur J Immunol. 2006 Dec;36(12):3288-93. doi: 10.1002/eji.200636234. Eur J Immunol. 2006. PMID: 17109469 Free article.

5

The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.

Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. Ishizuka J, et al. Among authors: bell ji. Immunity. 2008 Feb;28(2):171-82. doi: 10.1016/j.immuni.2007.12.018. Immunity. 2008. PMID: 18275829 Free article.

6

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.

Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, Poschmann G, Kaur G, Lambert L, Leach OA, Prömel S, Punwani D, Felce JH, Davis SJ, Gold R, Nielsen FC, Siegel RM, Mann M, Bell JI, McVean G, Fugger L. Gregory AP, et al. Among authors: bell ji. Nature. 2012 Aug 23;488(7412):508-511. doi: 10.1038/nature11307. Nature. 2012. PMID: 22801493 Free PMC article.

7

Weighing in on autoimmune disease: Big data tip the scale.

Dendrou CA, Bell JI, Fugger L. Dendrou CA, et al. Among authors: bell ji. Nat Med. 2013 Feb;19(2):138-9. doi: 10.1038/nm.3087. Nat Med. 2013. PMID: 23389608 No abstract available.

8

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

Dendrou CA, Bell JI, Fugger L. Dendrou CA, et al. Among authors: bell ji. Pharmacogenomics. 2013 Sep;14(12):1397-404. doi: 10.2217/pgs.13.140. Pharmacogenomics. 2013. PMID: 24024893

9

A structural basis for immunodominant human T cell receptor recognition.

Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. Stewart-Jones GB, et al. Among authors: bell ji. Nat Immunol. 2003 Jul;4(7):657-63. doi: 10.1038/ni942. Epub 2003 Jun 8. Nat Immunol. 2003. PMID: 12796775

10

The value of animal models for drug development in multiple sclerosis.

Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L. Friese MA, et al. Among authors: bell ji. Brain. 2006 Aug;129(Pt 8):1940-52. doi: 10.1093/brain/awl083. Epub 2006 Apr 24. Brain. 2006. PMID: 16636022 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page